Esperion Therapeutics Inc.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
1.6
0.04
(2.564%)
Volume:
8,132,846
52 week range:
1.26 - 8.87
Market Cap:
122.517M
Company Description:
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at Esperion is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.